Intermediate Capital buys Doc Generici

Intermediate Capital Group said April 8 that it invested in Doc Generici. Mérieux Equity Partners invested in the deal. CVC is the seller. Financial terms weren’t announced. Doc Generici is a generic pharmaceutical company in Italy. Gattai, Minoli, Agostinelli & Partners advised Intermediate Capital.

8 April 2019•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles